Welcome to our dedicated page for Cvs Health news (Ticker: CVS), a resource for investors and traders seeking the latest updates and insights on Cvs Health stock.
CVS Health Corporation operates an integrated health care model that combines retail pharmacy, pharmacy benefit management, health insurance, medical clinics, specialty and mail pharmacy support, and related consumer health services. Recurring company news includes quarterly results and guidance, segment performance across Health Services, Health Care Benefits, and Pharmacy & Consumer Wellness, and capital returns through common-stock dividends.
Updates also cover CVS Caremark formulary decisions, biosimilar adoption, Aetna prior authorization and plan-administration initiatives, community health investments by the CVS Health Foundation, and developments involving Omnicare, the company's long-term care pharmacy subsidiary.
CVS (NYSE:CVS) opened its first pharmacy-only location in Chicago on March 30, 2026, part of a plan to open nearly 20 pharmacy-only sites this year and more than 40 new CVS Pharmacy locations including traditional and Target stores. Sites average ~3,000 sq ft and focus on prescriptions, immunizations and pharmacist counseling.
The format complements existing store types and targets communities needing increased access to in-person pharmacy care.
CVS Health (NYSE: CVS) declared a quarterly dividend of $0.665 per share. The board approved the payment, which is payable on May 4, 2026 to shareholders of record on April 23, 2026.
This announcement details the dividend amount, record date, and payment date for common stockholders.
CVS Health (NYSE:CVS) is investing $2.24 million to launch a Health Zone in Charlotte's Historic West End through the Westside Wellness Collab led by LISC Charlotte.
The three‑year effort funds mobile clinics, fresh food distribution, care coordination and partner capacity building to improve chronic‑condition support and food access.
CVS Health (NYSE:CVS) announced a $2.24 million investment in Health Impact Ohio to launch a Health Zone in Columbus on March 10, 2026. The funding expands Community Health Worker capacity, maternal and behavioral health services, training and data systems to reduce avoidable emergency care and improve care coordination.
The investment builds on CVS's broader Ohio footprint, including workforce centers, affordable housing investments (~$80 million) and reported FY2024 economic contributions.
CVS Health (NYSE: CVS) and Google Cloud announced a strategic partnership to launch Health100, an AI-native consumer engagement platform aimed at creating a connected, proactive, and personalized health experience. The platform will use Google Cloud technologies including Gemini models, Cloud Healthcare API, and BigQuery.
Health100 is designed to enable real-time, omni-channel support, pharmacist-led care management, cost transparency, and future biometric wearable integration. Initial launch is planned for 2026 with a first look at The Check Up in March 2026.
CVS (NYSE:CVS) became an Official Health and Wellness Partner of the U.S. Soccer Federation and the National Women's Soccer League on Feb 19, 2026, backing a multi-year program to develop community multi-use soccer fields in select U.S. markets through 2028.
The sponsorship also includes club partnerships with Washington Spirit, Seattle Reign FC and Kansas City Current and community programs amplified by athletes and ambassadors.
CVS Health (NYSE: CVS) announced a $5 million scholarship program to support students pursuing a Doctor of Pharmacy (PharmD) at Xavier University of Louisiana and the University of Louisiana at Monroe.
The program aims to reduce financial barriers, strengthen Louisiana's pharmacy workforce, and expand access to care, starting in the 2026-27 academic year.
CVS Health (NYSE: CVS) reported fourth-quarter and full-year 2025 results with total revenues of $105.7B (Q4, +8.2% YoY) and a record $402.1B for the year (+7.8% YoY). GAAP diluted EPS was $2.30 in Q4 and $1.39 for the year; adjusted EPS was $1.09 in Q4 and $6.75 for the year.
The company generated $10.6B of operating cash flow in 2025, completed pharmacy reimbursement transitions, and cited $5.7B goodwill impairment and ~$1.2B legacy litigation charges that reduced operating income. 2026 adjusted EPS guidance: $7.00–$7.20; GAAP EPS guidance: $5.94–$6.14.
CVS (NYSE: CVS) announced that about 9,000 CVS Pharmacy locations now accept TrumpRx discount cards, allowing eligible patients to apply manufacturer-determined savings at the pharmacy counter.
CVS notes its 27,000 community pharmacists can help customers, and that CVS Specialty and NovoCare support reduced pricing for fertility medications via the TrumpRx Fertility program.
Aetna (NYSE: CVS) was named Press Ganey's inaugural Health Plan of the Year at the Human Experience (HX26) Conference on Feb. 5, 2026. The award recognizes sustained excellence in member experience, quality performance and provider collaboration, citing programs like the HX Exchange partnership with Press Ganey.